REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik